| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.1M | +63.4% |
| R&D Expense | $605K | -37.7% |
| SG&A Expense | $24.1M | +31.8% |
| Operating Income | -$157.7M | -699.6% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $166K | +1206.7% |
| Net Income | -$192.8M | -1015.2% |
| EPS (Basic) | -$2.91 | -401.7% |
| EPS (Diluted) | -$2.91 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -97.5% |
| Accounts Receivable | $174K | -3.9% |
| Current Assets | $10.3M | -86.9% |
| Total Assets | $83.0M | -69.9% |
| Current Liabilities | $6.2M | +19.0% |
| Total Liabilities | $12.0M | +90.3% |
| Stockholders' Equity | $34.9M | -87.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.8M | -7.9% |
| Capital Expenditures | $17.6M | -82.8% |
| Investing Cash Flow | -$22.0M | +82.0% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$48.4M | +63.0% |
| -401.7% |